Mike Gorenstein



Mike Gorenstein Recent News

Maximize Your Returns: Get To Know The Top Performing Cannabis Stocks Of The Last 12 Months
Cronos Q4 2022 Revenue Declines 11% YoY, What About Net Loss?
Meet Ivy League-Trained Lawyer Leading The Way In Cannabis Industry: Mike Gorenstein Of The Cronos Group
Cronos Launches Spinach FEELZ Day Trip Gummies With THC And CBC
Key Cannabis Exec Changes You Need To Know About: Who's Florida's New MMJ Czar & More Industry Appointments
Cronos Q3 Revenue Stagnates, Remains On Track For $20M In Operating Expense Savings
Cronos Q2 2022 Revenue Grows 47% YoY, Company Focused On Rare Cannabinoids
Cronos Partners With Geocann To Launch CBD Gel Capsules By Lord Jones Utilizing VESIsorb For Faster Absorption
Cronos Q1 Revenue Improves 101.61% YoY, Cannabis Company Attributes Growth To This
Cronos Group's Mike Gorenstein Returns As CEO
Cannabis Producer Cronos Plunges On $107M Loss, Says Pricing Pressures Drove Write-Downs
Cronos CEO Talks Vaping With Cramer
Cronos Group Trades Higher After Revenue Jumps Three-Fold In Q2
Cronos To Acquire 4 Redwood Subsidiaries, Expand Growth In US CBD Market
Cronos Group Will Acquire GMP Compliant Fermentation, Manufacturing Facility
Cronos Group Names Todd Abraham As New Chief Innovation Officer
Cronos Group Signs Multiyear Supply Agreement With MediPharm Labs
Marlboro Maker Altria Takes 45% Stake In Cronos Group
Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week
Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week
Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week